Reuters -- Immunomedics Inc posted a quarterly profit on collaboration revenue and said it expects cash expenditures in 2010 to be at a higher level to support an "aggressive" clinical development agenda.
Reuters -- Immunomedics Inc posted a quarterly profit on collaboration revenue and said it expects cash expenditures in 2010 to be at a higher level to support an "aggressive" clinical development agenda.
